Literature DB >> 15485997

A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population.

L Caponi1, E Petit-Teixeira, M Sebbag, F Bongiorni, S Moscato, F Pratesi, C Pierlot, J Osorio, S Chapuy-Regaud, M Guerrin, F Cornelis, G Serre, P Migliorini.   

Abstract

BACKGROUND: Autoantibodies to citrullinated proteins (ACPA) are considered a specific marker for rheumatoid arthritis. Peptidylarginine deiminase (PAD) is the enzyme that converts arginyl into citrullyl residues; different isoforms of the enzyme are expressed in mammals. It has been suggested that the PADI4 gene may contribute to genetic susceptibility to rheumatoid arthritis, but conflicting results have been obtained in different populations.
OBJECTIVE: To test the hypothesis that the PADI4 gene may confer susceptibility to rheumatoid arthritis in a white French population, using powerful and highly reliable family based association tests.
METHODS: DNA samples were analysed from 100 families where one member was affected by rheumatoid arthritis and both parents were available for sampling. Five single nucleotide polymorphisms, located within the PADI4 gene and in its close proximity, were genotyped by restriction fragment length polymorphism, and haplotypes were constructed. The analysis involved use of the transmission disequilibrium test and genotype relative risk. ACPA were detected by ELISA on cyclic citrullinated peptides and on human deiminated fibrinogen.
RESULTS: No single SNP or haplotype was associated with the disease, or was preferentially transmitted. No association was found when patients were partitioned according to ACPA positivity.
CONCLUSIONS: No PADI4 haplotype is associated with rheumatoid arthritis in a white French population. The role of genes encoding the other PAD isoforms, or modulating tissue expression or enzyme activity, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485997      PMCID: PMC1755438          DOI: 10.1136/ard.2004.026831

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  44 in total

1.  Faster multipoint linkage analysis using Fourier transforms.

Authors:  L Kruglyak; E S Lander
Journal:  J Comput Biol       Date:  1998       Impact factor: 1.479

2.  Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat.

Authors:  T Nishijyo; A Kawada; T Kanno; M Shiraiwa; H Takahara
Journal:  J Biochem       Date:  1997-05       Impact factor: 3.387

3.  Peptidylarginine deiminase of the hair follicle: characterization, localization, and function in keratinizing tissues.

Authors:  G Rogers; B Winter; C McLaughlan; B Powell; T Nesci
Journal:  J Invest Dermatol       Date:  1997-05       Impact factor: 8.551

4.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.

Authors:  Akari Suzuki; Ryo Yamada; Xiaotian Chang; Shinya Tokuhiro; Tetsuji Sawada; Masakatsu Suzuki; Miyuki Nagasaki; Makiko Nakayama-Hamada; Reimi Kawaida; Mitsuru Ono; Masahiko Ohtsuki; Hidehiko Furukawa; Shinichi Yoshino; Masao Yukioka; Shigeto Tohma; Tsukasa Matsubara; Shigeyuki Wakitani; Ryota Teshima; Yuichi Nishioka; Akihiro Sekine; Aritoshi Iida; Atsushi Takahashi; Tatsuhiko Tsunoda; Yusuke Nakamura; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

6.  Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.

Authors:  Jonathan A Hill; Scott Southwood; Alessandro Sette; Anthony M Jevnikar; David A Bell; Ewa Cairns
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

7.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Authors:  Solbritt Rantapää-Dahlqvist; Ben A W de Jong; Ewa Berglin; Göran Hallmans; Göran Wadell; Hans Stenlund; Ulf Sundin; Walther J van Venrooij
Journal:  Arthritis Rheum       Date:  2003-10

Review 8.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease.

Authors:  Erik R Vossenaar; Albert J W Zendman; Walther J van Venrooij; Ger J M Pruijn
Journal:  Bioessays       Date:  2003-11       Impact factor: 4.345

9.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.

Authors:  Markus M J Nielen; Dirkjan van Schaardenburg; Henk W Reesink; Rob J van de Stadt; Irene E van der Horst-Bruinsma; Margret H M T de Koning; Moud R Habibuw; Jan P Vandenbroucke; Ben A C Dijkmans
Journal:  Arthritis Rheum       Date:  2004-02

10.  ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets.

Authors:  Paul W Wright; Laura C Bolling; Meredith E Calvert; Olga F Sarmento; Elizabeth V Berkeley; Margaret C Shea; Zhonglin Hao; Friederike C Jayes; Leigh Ann Bush; Jagathpala Shetty; Amy N Shore; Prabhakara P Reddi; Kenneth S Tung; Eileen Samy; Margaretta M Allietta; Nicholas E Sherman; John C Herr; Scott A Coonrod
Journal:  Dev Biol       Date:  2003-04-01       Impact factor: 3.582

View more
  29 in total

1.  Evaluation of allele frequencies in the PADI4 gene and anti-cyclic citrullinated peptide antibodies of patients with rheumatoid arthritis in a Japanese population.

Authors:  M Suzuki; J Miyagi; M Kuribayashi; E Negishi; K Ueno; H Moriya
Journal:  Ann Rheum Dis       Date:  2006-10       Impact factor: 19.103

2.  Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae
Journal:  Clin Rheumatol       Date:  2015-10-16       Impact factor: 2.980

3.  Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis.

Authors:  K Ikari; S Momohara; T Nakamura; M Hara; H Yamanaka; T Tomatsu; N Kamatani
Journal:  Ann Rheum Dis       Date:  2005-09-21       Impact factor: 19.103

Review 4.  Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis.

Authors:  Vasanth Konda Mohan; Nalini Ganesan; Rajasekhar Gopalakrishnan
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

5.  Association and expression study of PRKCH gene in a French Caucasian population with rheumatoid arthritis.

Authors:  Vitor Hugo Teixeira; Laurent Jacq; Jeoiakim Moore; Sandra Lasbleiz; Pascal Hilliquin; Catarina Resende Oliveira; François Cornelis; Elisabeth Petit-Teixeira
Journal:  J Clin Immunol       Date:  2007-10-24       Impact factor: 8.317

6.  What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases.

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

Review 7.  Genetics of rheumatic disease.

Authors:  Alex Clarke; Timothy J Vyse
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

8.  Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.

Authors:  So-Young Bang; Tae-Un Han; Chan-Bum Choi; Yoon-Kyoung Sung; Sang-Cheol Bae; Changwon Kang
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

9.  The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets.

Authors:  Jade E Hollis-Moffatt; Kerry A Rowley; Amanda J Phipps-Green; Marilyn E Merriman; Nicola Dalbeth; Peter Gow; Andrew A Harrison; John Highton; Peter B B Jones; Lisa K Stamp; Pille Harrison; B Paul Wordsworth; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2009-10-09       Impact factor: 5.156

Review 10.  Developments in the scientific understanding of rheumatoid arthritis.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.